Yahoo Finance5 天
IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in ...
POTOMAC, MD / ACCESS Newswire / March 26, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced additional positive interim results from its ongoing Phase 2 ...